Of Counsel Benjamin Zegarelli shared key insights with MD+DI on the American Clinical Laboratory Association's (ACLA's) lawsuit against the FDA for their laboratory-developed test (LDT) ruling.
Benjamin commented on previous LDT enforcement, stating since 1988, "LDTs and the clinical laboratories that develop and commercialize them have had to comply with CLIA and state laws relating to laboratory operations but were not required to comply with FDA's medical device regulations due to the agency's historical policy of enforcement discretion for LDTs."
SOURCE
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
